18554161. METHODS AND KITS FOR DIAGNOSING CANCER AND PREDICTING RESPONSE TO TREATMENT BASED ON CENP-A LABELLING (CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE)
Contents
METHODS AND KITS FOR DIAGNOSING CANCER AND PREDICTING RESPONSE TO TREATMENT BASED ON CENP-A LABELLING
Organization Name
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE
Inventor(s)
Geneviève Almouzni of NEUILLY SUR SEINE (FR)
Jean-Pierre Quivy of VINCENNES (FR)
Frédérique Berger of PARIS (FR)
METHODS AND KITS FOR DIAGNOSING CANCER AND PREDICTING RESPONSE TO TREATMENT BASED ON CENP-A LABELLING
This abstract first appeared for US patent application 18554161 titled 'METHODS AND KITS FOR DIAGNOSING CANCER AND PREDICTING RESPONSE TO TREATMENT BASED ON CENP-A LABELLING
Original Abstract Submitted
Cell fusion techniques have been used to produce hybrids between myeloma cells and antibody-producing cells. The hybrid lines derived are permanently adapted to grow in tissue culture and are capable of inducing antibody-producing tumors in mice.
